110 related articles for article (PubMed ID: 36975744)
1. Mpox (monkeypox): Diagnosis, prevention, and management in adults.
Jarrell L; Perryman K
Nurse Pract; 2023 Apr; 48(4):13-20. PubMed ID: 36975744
[TBL] [Abstract][Full Text] [Related]
2. Treatment and Vaccination for Smallpox and Monkeypox.
Saalbach KP
Adv Exp Med Biol; 2024; 1451():301-316. PubMed ID: 38801586
[TBL] [Abstract][Full Text] [Related]
3. Mini Review on Clinical Aspects of Monkeypox.
Saraswat Y; Shah K
Curr Pharm Biotechnol; 2024; 25(4):411-425. PubMed ID: 37711132
[TBL] [Abstract][Full Text] [Related]
4. Clinical considerations on monkeypox antiviral medications: An overview.
Pourkarim F; Entezari-Maleki T
Pharmacol Res Perspect; 2024 Feb; 12(1):e01164. PubMed ID: 38149674
[TBL] [Abstract][Full Text] [Related]
5. Recent Advances in the Prevention and Management of Monkeypox Viral Infection in Humans.
Gujjar P; Chaudhay R; Verma I; Bansal N; Gupta S; Bansal S
Curr Drug Targets; 2023; 24(13):1032-1045. PubMed ID: 37842888
[TBL] [Abstract][Full Text] [Related]
6. Update on monkeypox virus infection: Focusing current treatment and prevention approaches.
Dhapola R; Kumari S; Sharma P; KumarKushawaha P; HariKrishnaReddy D
Fundam Clin Pharmacol; 2024 Jun; 38(3):465-478. PubMed ID: 38226405
[TBL] [Abstract][Full Text] [Related]
7. Potential therapeutic targets for Mpox: the evidence to date.
Byrareddy SN; Sharma K; Sachdev S; Reddy AS; Acharya A; Klaustermeier KM; Lorson CL; Singh K
Expert Opin Ther Targets; 2023; 27(6):419-431. PubMed ID: 37368464
[TBL] [Abstract][Full Text] [Related]
8. Potential use of cidofovir, brincidofovir, and tecovirimat drugs in fighting monkeypox infection: recent trends and advancements.
Rani I; Joshi H; Sharma U; Kaur J; Sood S; Ramniwas S; Chauhan A; Abdulabbas HS; Tuli HS
Naunyn Schmiedebergs Arch Pharmacol; 2024 Apr; 397(4):2055-2065. PubMed ID: 37837475
[TBL] [Abstract][Full Text] [Related]
9. Insights into the Transmission, Host Range, Genomics, Vaccination, and Current Epidemiology of the Monkeypox Virus.
Araf Y; Nipa JF; Naher S; Maliha ST; Rahman H; Arafat KI; Munif MR; Uddin MJ; Jeba N; Saha S; Zhai J; Hasan SMN; Xue M; Hossain MG; Zheng C
Vet Med Int; 2024; 2024():8839830. PubMed ID: 38836166
[TBL] [Abstract][Full Text] [Related]
10. Non-Healing Corneal Ulcer and Uveitis Following Monkeypox Disease: Diagnostic and Therapeutic Challenges.
Androudi S; Kaufman AR; Kouvalakis A; Mitsios A; Sapounas S; Al-Khatib D; Schibler M; Pineda R; Baglivo E
Ocul Immunol Inflamm; 2024 Apr; 32(3):253-258. PubMed ID: 37140328
[TBL] [Abstract][Full Text] [Related]
11. Early administration of tecovirimat shortens the time to mpox clearance in a model of human infection.
Nguyen BT; Marc A; Suñer C; Marks M; Ubals M; Hernández-Rodríguez Á; Melendez MÁ; ; Hruby DE; Russo AT; Mentré F; Mitjà O; Grosenbach DW; Guedj J
PLoS Biol; 2023 Dec; 21(12):e3002249. PubMed ID: 38127878
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and viral dynamics of tecovirimat in patients with MPOX: A multicenter open-label, double-arm trial in Japan.
Akiyama Y; Morioka S; Tsuzuki S; Yoshikawa T; Yamato M; Nakamura H; Shimojima M; Takakusaki M; Saito S; Takahashi K; Sanada M; Komatsubara M; Takebuchi K; Yamaguchi E; Suzuki T; Shimokawa K; Kurosu T; Kawahara M; Oishi K; Ebihara H; Ohmagari N
J Infect Chemother; 2024 Jun; 30(6):488-493. PubMed ID: 38042298
[TBL] [Abstract][Full Text] [Related]
13. Trifluridine for treatment of mpox infection in drug combinations in ophthalmic cell models.
Cinatl J; Bechtel M; Reus P; Ott M; Rothweiler F; Michaelis M; Ciesek S; Bojkova D
J Med Virol; 2024 Jan; 96(1):e29354. PubMed ID: 38180134
[TBL] [Abstract][Full Text] [Related]
14. Reduced Odds of Mpox-Associated Hospitalization Among Persons Who Received JYNNEOS Vaccine - California, May 2022-May 2023.
Schildhauer S; Saadeh K; Vance J; Quint J; Salih T; Lo T; Keinde A; Chojolan E; Gotlieb E; Ramos M; Chapman E; Peters P; Watson J; Johnson KA; Tang EC; Jacobson K; Snyder RE
MMWR Morb Mortal Wkly Rep; 2023 Sep; 72(36):992-996. PubMed ID: 37676838
[TBL] [Abstract][Full Text] [Related]
15. The global patent landscape of emerging infectious disease monkeypox.
Cai Y; Zhang X; Zhang K; Liang J; Wang P; Cong J; Xu X; Li M; Liu K; Wei B
BMC Infect Dis; 2024 Apr; 24(1):403. PubMed ID: 38622539
[TBL] [Abstract][Full Text] [Related]
16. Breaking Barriers: Current Advances and Future Directions in Mpox Therapy.
Shah BM; Modi P
Curr Drug Targets; 2024; 25(1):62-76. PubMed ID: 38151842
[TBL] [Abstract][Full Text] [Related]
17. Challenges in Managing Treatment-Resistant Mpox Complicated by Severe Superinfection.
Fortier JC; Marsalisi C; Cordova E; Guo HJ; Verdecia J
Open Forum Infect Dis; 2024 Apr; 11(4):ofae138. PubMed ID: 38651138
[TBL] [Abstract][Full Text] [Related]
18. Mpox Vaccine Interest Survey Prioritization and Data Flow: Maricopa County, Arizona, July-August 2022.
Howard BJ; Collins JE; Staab RN; Singh S; Lara E; Kretschmer M; Rehder L; Dellos A; White JR; Dale AP
Am J Public Health; 2023 May; 113(5):504-508. PubMed ID: 36893362
[TBL] [Abstract][Full Text] [Related]
19. Severe Presentation of Mpox With Skin, Lung and Pleural Involvement in a Non-HIV Infected Kidney Transplant Recipient.
Colina-García JF; Caso JM; González-García C; Folgueira MD; Hernández AM; Auñón P; Andrés A; Cavero T; López-Medrano F; Morales E
Am J Kidney Dis; 2024 Jun; ():. PubMed ID: 38866126
[TBL] [Abstract][Full Text] [Related]
20. Surveillance of Complicated Mpox Cases Unresponsive to Oral Tecovirimat in Los Angeles County, 2022.
Karan A; Shah N; Garrigues JM; Alarcόn J; Hemarajata P; Finn LE; Poortinga K; Danza P; Kulkarni S; Kim M; Terashita D; Green NM; Balter S
J Infect Dis; 2024 Mar; 229(Supplement_2):S249-S254. PubMed ID: 37995310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
